Hemo Organic Intrinsic Value
HEMORGANIC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.57 | ₹4.46 - ₹6.68 | -70.0% | EPS: ₹0.40, Sector P/E: 12x |
| Revenue Multiple Method | revenue | ₹6.00 | ₹5.40 - ₹6.60 | -67.7% | Revenue/Share: ₹7.50, P/S: 0.8x |
| PEG Ratio Method | growth | ₹5.57 | ₹5.01 - ₹6.13 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹5.57 | ₹5.01 - ₹6.13 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
Want to compare with current market value? Check HEMORGANIC share price latest .
Valuation Comparison Chart
HEMORGANIC Intrinsic Value Analysis
What is the intrinsic value of HEMORGANIC?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Hemo Organic (HEMORGANIC) is ₹5.57 (median value). With the current market price of ₹18.57, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹5.57 to ₹6.00, indicating ₹5.57 - ₹6.00.
Is HEMORGANIC undervalued or overvalued?
Based on our multi-method analysis, Hemo Organic (HEMORGANIC) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Hemo Organic
Additional stock information and data for HEMORGANIC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |